SVB Leerink Reiterates Outperform Rating on bluebird bio (BLUE) on Updated KarMMa Study Data
Tweet Send to a Friend
SVB Leerink analyst Mani Foroohar reiterated an Outperform rating and $68.00 price target on bluebird bio (NASDAQ: BLUE) after abstracts ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
